Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Additional Paid-In Capital
$4,368 Mil (As of Sep. 2014)

GlaxoSmithKline PLC's quarterly additional paid-in capital increased from Mar. 2014 ($4,481 Mil) to Jun. 2014 ($4,618 Mil) but then declined from Jun. 2014 ($4,618 Mil) to Sep. 2014 ($4,368 Mil).

GlaxoSmithKline PLC's annual additional paid-in capital increased from Dec. 2011 ($2,598 Mil) to Dec. 2012 ($3,230 Mil) and increased from Dec. 2012 ($3,230 Mil) to Dec. 2013 ($4,275 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
AdditionalPaidInCapital 5719711,6812,4941,9162,2102,2522,5983,2304,275

GlaxoSmithKline PLC Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
AdditionalPaidInCapital 2,9283,1433,2303,2763,7034,0374,2754,4814,6184,368
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK